Published 3 months ago • loading... • Updated 3 months ago

Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation

Rosen Law Firm on Dec. 3, 2025, encouraged shareholders of Tandem Diabetes Care, Inc. to inquire about a securities class action investigation, as it prepares a lawsuit over device correction and stock drop.
On August 7, 2025, Tandem Diabetes Care, Inc. announced a voluntary medical device correction for select t:slim X2 insulin pumps, causing its stock to fall 19.9%.
Rosen Law Firm has a track record, including Laurence Rosen, founding partner, being named a 'Titan of Plaintiffs' Bar' and securing over $438 million in 2019.
Rosen asks affected shareholders to submit claims via https://rosenlegal.com/submit-form/?case_id=19024 or call Phillip Kim, Esq. at toll-free 686 to seek compensation without out-of-pocket fees.
The firm has long-standing recognition, with Rosen Law Firm holding a top 4 ranking since 2013 and ISS Securities Class Action Services tracking their settlements and recoveries.

Insights by Ground AI